Orient Bio Inc
KRX:002630

Watchlist Manager
Orient Bio Inc Logo
Orient Bio Inc
KRX:002630
Watchlist
Price: 635 KRW -1.4% Market Closed
Market Cap: 75.3B KRW

Operating Margin
Orient Bio Inc

-15.6%
Current
-5%
Average
3.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-15.6%
=
Operating Profit
-4.6B
/
Revenue
29.7B

Operating Margin Across Competitors

No Stocks Found

Orient Bio Inc
Glance View

ORIENTBIO, Inc. engages in the research and development of biotechnology. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 104 full-time employees. The firm produces and supplies laboratory animals, including mice, rats, guinea pigs, hamsters, specific pathogen free (SPF) rabbits, beagles and others. The company also provides contract research organization (CRO) services, including CRO safety assessment and CRO new drug development services; medical and library equipment, such as barrier systems, and support services such as rodent surgery services, laboratory diagnostics services, transgenic services, genetic testing services and other services. In addition, along with its subsidiaries, the Company provides feeds, reagents, disinfectants, automobile components, power supply equipment, and other machines.

Intrinsic Value
361.5 KRW
Overvaluation 43%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-15.6%
=
Operating Profit
-4.6B
/
Revenue
29.7B
What is the Operating Margin of Orient Bio Inc?

Based on Orient Bio Inc's most recent financial statements, the company has Operating Margin of -15.6%.

Back to Top